Jarden Research Adjusts Telix Pharmaceuticals' Price Target to AU$16.62 From AU$13.94, Keeps at Buy
Jarden Research Adjusts Telix Pharmaceuticals' Price Target to AU$16.62 From AU$13.94, Keeps at Buy
Jarden Research将Telix Pharmicals的目标股价从13.94澳元调整至16.62澳元,维持买入状态
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册